Compare Newmont Corporation (NEM) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newmont Corporation vs Nuvalent Inc — how do they compare? Newmont Corporation trades at $92.41 (market cap $95.23B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Newmont Corporation is far larger — about 9.7× Nuvalent Inc's market cap, and Newmont Corporation pays a 1.17% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NEM | NUVL | |
|---|---|---|
Market Cap | $95.23B | $9.81B |
Sector | Basic Materials | Technology |
52-Week High | $131.95 | $123.96 |
52-Week Low | $59.86 | $72.16 |
Enterprise Value | $91.98B | $8.52B |
Dividend Yield | 1.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
